On 11 June 2013, the European Commission (“Commission”) adopted a proposal for a directive on how citizens and companies can bring damages claims under EU antitrust rules. According to the Commission, the proposal serves to...more
6/13/2013
- Antitrust Litigation EU European Commission
I. Introduction -
The EU has renewed its sanctions against Syria until 1 June 2014, with the exception of the arms embargo.
For Belarus, the Council has decided to delist three parties from the asset freeze...more
6/5/2013
- Arms Embargo EU Frozen Assets Middle East Sanctions
I. Introduction -
The EU has updated its sanctions measures against Burma/Myanmar, Syria, North Korea and Libya.
For Burma/Myanmar, the Council has decided to lift all economic sanctions, while keeping the...more
4/24/2013
- EU Frozen Assets Sanctions United Nations
I. Introduction -
The EU has updated its sanctions measures against Syria, North Korea and Zimbabwe.
For Syria, the Council has renewed its sanctions for a further three months, while introducing certain...more
3/5/2013
- Arms Embargo EU Sanctions
On 21 December 2012, the Council of the European Union (EU) adopted the EU-wide legislation clarifying important details of the expanded sanctions measures already agreed by the Council in broad terms on 15 October 2012.1...more
1/14/2013
- EU Iran Sanctions Natural Gas Oil & Gas
On 11 December 2012, Advocate General Bot gave his Opinion on Joined Cases C- 274/11 and 295/11, proposing that the Court of Justice of the European Union (“ECJ”) dismiss the cases brought by Spain and Italy challenging the...more
12/20/2012
- EU Unified Patent Court Unitary Patent
Introduction -
On 6 December 2012, the European Court of Justice (the “ECJ”) upheld the judgment of the General Court (“GC”), which found that AstraZeneca (“AZ”) abused its dominant position on the market for proton pump...more
12/14/2012
- Competition European Commission Patents Pharmaceutical
Introduction -
Across Europe, as public budgets are tightened, there is pressure to lower spending on prescription medicines. These well-understandable budgetary pressures have led to some controversial suggestions,...more
12/11/2012
- Off-Label Use Pharmaceutical
